Anti-IL-1RAP/IL-1R3 Antibody (Nidanilimab)
Catalog No.
F1290
Anti-IL-1RAP/IL-1R3 Antibody (Nidanilimab)
Featured Products
Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAP antibody with a Kd value of 1.10 pM. Nidanilimab blocks the IL1α and IL1β signaling pathways and stimulates the immune system to destroy tumor cells. Nidanilimab can be used in the research of non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.48 kDa
Dry ice
2171061-85-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CAN04, nadunolimab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NPH3
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-1RAP / IL-1R3
Please avoid freeze-thaw cycles.